Global Medical REIT Reduces Quarterly Dividend to $0.15

Global Medical REIT ( (GMRE) ) has provided an announcement.

On May 28, 2025, Global Medical REIT announced a reduction in its quarterly cash dividend from $0.21 to $0.15 per share, effective for stockholders of record as of June 20, 2025, and payable on July 9, 2025. This strategic move aims to position the company for future growth by enhancing balance sheet flexibility and generating additional free cash flow to reduce leverage and improve capital costs, while ensuring a well-covered dividend for investors.

The most recent analyst rating on (GMRE) stock is a Buy with a $11.75 price target. To see the full list of analyst forecasts on Global Medical REIT stock, see the GMRE Stock Forecast page.

Spark’s Take on GMRE Stock

According to Spark, TipRanks’ AI Analyst, GMRE is a Neutral.

Global Medical REIT’s overall score is impacted by strong financials, particularly in revenue growth and cash flow, but offset by low profitability metrics and high valuation concerns. Technical indicators suggest weak momentum. The mixed sentiment from the earnings call, with strategic positives counterbalanced by revenue and tenant issues, contributes to a cautious outlook.

To see Spark’s full report on GMRE stock, click here.

More about Global Medical REIT

Global Medical REIT Inc. operates in the healthcare real estate industry, primarily investing in off-campus, outpatient medical facilities, and post-acute, inpatient medical facilities. The company focuses on acquiring properties with attractive capitalization rates and tenants that are profitable national or regional healthcare systems or physician groups, leveraging an experienced management team to maximize returns for investors.

Average Trading Volume: 590,305

Technical Sentiment Signal: Sell

Current Market Cap: $461.4M

Find detailed analytics on GMRE stock on TipRanks’ Stock Analysis page.